Skip to main content
. Author manuscript; available in PMC: 2013 May 5.
Published in final edited form as: Endocr Relat Cancer. 2011 Feb 23;18(2):207–219. doi: 10.1677/ERC-10-0049

Figure 3. EHT 1864 inhibits estrogen-induced breast cancer cell proliferation.

Figure 3

MCF7 (A), T47D (B) and MDA MB 231 (C) cells were treated with either vehicle, 1 nM estradiol and/or 10 μM EHT 1864. Total cells that excluded trypan blue were counted on the indicated days. (D) T47D cells were treated with vehicle, 500 nM tamoxifen, 10 μM EHT 1864 or tamoxifen plus EHT 1864 in the presence and absence of 1 nM estradiol. Cells were counted as described above 5 days after treatment. P-values were determined by comparing each treatment group to control using student t-test. * P < 0.05.